OsmoCarb™ Complex Carbohydrate Information & Suggested Uses

Rule of Thumb Fuel Intake per body weight is:

30g after the first 60 min is enough for training lasting 60-90 min.
60 g per hour after the first 2 - 2.5 hours
90 g per hour after 3 hours → dependent on high intensity exercise (~75% of maximal effort)

Protocol For Use:

Primary fuel source during 1st 3/4 of an endurance race: Triathlon, Marathon, Century. 

Amounts based on your personal caloric needs, combined with electrolyte beverage to your water bottle 

OSMOCARB™ Can be combined with other simple or complex carbohydrate sources as needed.

Each Serving = 2 Rounded Tbps
  • 15 Carbs
  • 57 Calories

Personalize your Caloric Consumption for Maximum Results

Hourly carbohydrate consumption is extremely individualized, and our solution is to provide the best known absorbable fuel source separately, as an ADD-IN to your  existing 'non-carbohydrate' electrolyte beverage.
These glycoside bonds in OsmoCarb™️ have a very low molecular weight, thus the osmotic pressure is lower than blood; creating a ‘hypotonic’ environment, enabling rapid intestinal absorption pushing fluids through the cell walls. 1

Faster Gastric Emptying than dextrin, maltodextrin, sugars.

Reduces Bloating & Excessive gas while racing and training

Clinical evidence concludes that hypotonic drinks are faster absorbed to increase endurance.  2

OsmoCarb™️ is composed of cyclic carbohydrate chains which are packed into tight clusters via enzymatic breakdown and resulting in Amylopectin.
Amylopectin consists of easy to digest glycoside bonds, resulting in EASY digestion.

Cluster Dextrin® (Highly Branched Cyclic Dextrin) is a new type of dextrin that is produced from amylopectin via a cyclization reaction of a branching enzyme (BE, 1,4-α-D-glucan: 1,4-α-D-glucan 6-α-D-(1,4-α-D-glucano)-transferase, EC 2.4.1.18). Ezaki Glico has successfully achieved industrial production of Cluster Dextrin® by applying its unique technology in enzymology. Glico obtained FDA Notified GRAS status for Cluster Dextrin® in October 2012.
References:
  1. Int J Sports Med, 26: 314-319, 2005
  2. Biosci Biotechnol Biochem, 63: 2045-2052, 1999